Lipocine LPCN
NASDAQ LPCN
$2.06 -0.03 (-1.44%)
As of: Aug 21, 2026 · 2:44 PM EDT

Lipocine (LPCN) Operating Margin Growth (3y) (2024 - 2025)

Lipocine (LPCN) Operating Margin Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.03 Bn 131.18 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -204.00
3 Argenx Se 64.93 Bn 59.75 Bn 1.37 Bn -537.00
4 Moderna 57.93 Bn 52.80 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 41.95 Bn 36.86 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.51 Bn 28.20 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.00 Bn 9.60 Bn 668.28 Mn -11,254.00
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.29 Bn 26.45 Bn - -2,649.00
10 Lipocine 11.15 Mn -12.76 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 31,948.00
Dec 31, 2024 -3,521.00